Fairvalue-Calculator Fairvalue-Calculator
EN DE

CelLBxHealth plc (CLBX) Fair Value & Analysis

Healthcare · GB · Market cap 38.8M GBX

Pricep0.0153
Fair Valuep0.0400
Upside+162.3%
Quality88/100
Evidence: Low Range p0.0300 – p0.0500

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

CelLBxHealth plc (CLBX) currently trades at p0.0153, while our model-based Fair Value estimate is p0.0400 — implying the stock looks roughly 162.3% undervalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including CTC enrichment and liquid biopsy analysis services; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DN…

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -96% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is CelLBxHealth plc (CLBX) undervalued?
As of Jun 25, 2026, our model estimates a fair value of p0.0400 versus a price of p0.0153 — about +162% (undervalued). Model-based estimate, not financial advice.
What is the fair value of CLBX?
Our 21-model fair value for CelLBxHealth plc is p0.0400 (as of Jun 25, 2026), built from audited fundamentals. The current price is p0.0153.
What is the quality score of CLBX?
CelLBxHealth plc has a Quality Score of 88/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.